Robert F. Kennedy Jr., the prospective health secretary, has made investments in biotechnology and had multiple sources of income in 2022 and 2023, according to financial disclosures obtained through a public records request by STAT. These documents shed light on Kennedy’s financial situation as he navigates the confirmation process in the Senate.
As the potential head of the Department of Health and Human Services, Kennedy would be required to adhere to a code of ethics that emphasizes the avoidance of financial conflicts of interest. This issue has been a central focus of Kennedy’s “Make America Healthy Again” campaign. In order to comply with these ethical guidelines, Kennedy would need to cease practicing law, unless it is pro bono work for the community or if he receives permission from the deputy attorney general to continue.
Last year, Kennedy’s tax filings revealed that he was earning over $20,000 per week as the chairman and chief legal counsel of his nonprofit organization, Children’s Health Defense. However, he took a leave of absence from these roles on April 1, 2023, and ceased receiving any pay or benefits. This move was likely in preparation for his presidential run and his potential appointment as the health secretary.
Kennedy’s financial disclosures also show that he has invested in biotechnology, indicating a diverse portfolio of income sources. This could potentially raise questions about conflicts of interest, as the health secretary would be involved in making decisions that could impact the biotechnology industry.
Overall, Kennedy’s financial situation is under scrutiny as he seeks confirmation for the role of health secretary. His adherence to ethical guidelines and the transparency of his financial dealings will be closely monitored by lawmakers and the public.
